Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CADL Candel Therapeutics, Inc.

Market Closed 09-25 16:00:00 EDT

11.02

-0.53

-4.59%

盘后11.07

+0.05+0.45%

19:59 EDT

High11.55	Low11.01	Vol799.76K
Open11.50	D1 Closing11.55	Amplitude4.68%
Mkt Cap843.23M	Tradable Cap661.83M	Total Shares76.52M
T/O8.97M	T/O Rate1.33%	Tradable Shares60.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":11.02,"timestamp":1790366400000,"preClose":11.55,"halted":0,"volume":799764,"hourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.02,"latestTime":"19:59 EDT","volume":9024,"amount":99464.81,"timestamp":1790380772538,"change":0.05,"changeRate":0.004537,"amplitude":0.004537},"delay":0,"changeRate":-0.045887445887445984,"floatShares":60056800,"shares":76518600,"eps":-1.438968,"marketStatus":"Market Closed","change":-0.53,"latestTime":"09-25 16:00:00 EDT","open":11.5,"high":11.55,"low":11.01,"amount":8966469.311016,"amplitude":0.046753,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.438968,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790582400000},"marketStatusCode":7,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":11.55,"preHourTrading":{"tag":"盘前","latestPrice":11.27,"preClose":11.55,"latestTime":"09:25 EDT","volume":4840,"amount":55947.486319999996,"timestamp":1790342700014,"change":-0.28,"changeRate":-0.024242,"amplitude":0.030303},"postHourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.02,"latestTime":"19:59 EDT","volume":9024,"amount":99464.81,"timestamp":1790380772538,"change":0.05,"changeRate":0.004537,"amplitude":0.004537},"volumeRatio":0.5589297697069949,"impliedVol":0.7898,"impliedVolPercentile":0.3466},"requestUrl":"/m/hq/s/CADL/","defaultTab":"news","newsList":[{"id":"2669955160","title":"Candel Therapeutics Shares Rise After BofA Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2669955160","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669955160?lang=en_us&edition=fundamental","pubTime":"2026-09-22 02:37","pubTimestamp":1790015866,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) shares rose 3.9% in Monday trading after BofA upgraded the stock to buy from neutral.Trading volume stood at 631,000 shares, compared with a daily average of about 1.4 million.Price: 11.27, Change: +0.42, Percent Change: +3.88","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669670891","title":"H.C. Wainwright Remains a Buy on Candel Therapeutics (CADL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669670891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669670891?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:56","pubTimestamp":1790013364,"startTime":"0","endTime":"0","summary":"In a report released today, Andres Y. Maldonado from H.C. Wainwright maintained a Buy rating on Candel Therapeutics, with a price target of $23.00....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-candel-therapeutics-cadl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-candel-therapeutics-cadl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CADL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150897","title":"BofA Upgrades Candel Therapeutics to Buy From Neutral, Price Target is $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150897","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150897?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:53","pubTimestamp":1789987987,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) has an average rating of buy and mean price target of $21.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669981150","title":"Candel Therapeutics upgraded to Buy from Neutral at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2669981150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669981150?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:40","pubTimestamp":1789987240,"startTime":"0","endTime":"0","summary":"BofA upgraded Candel Therapeutics (CADL) to Buy from Neutral with a price target of $18, up from $12. A mature prostate cancer package, on track fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-upgraded-to-buy-from-neutral-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-upgraded-to-buy-from-neutral-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666572249","title":"Candel Therapeutics CEO Paul Peter Tak Disposes of Common Shares Worth $3,164,815.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2666572249","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666572249?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:12","pubTimestamp":1789164760,"startTime":"0","endTime":"0","summary":"Candel Therapeutics CEO Paul Peter Tak disposes of common shares worth $3,164,815.85Paul Peter Tak, Chief Executive Officer, cut his direct stake in Candel Therapeutics to 113,321 shares.Disposed of 280,245 shares on Sep. 10-11 at weighted average prices of $11.5 and $10.46.Exercised options for 125,000 shares at $1.55 on Sep. 10.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL7GNqtL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Candel Therapeutics CEO Paul Peter Tak Disposes of Common Shares Worth $3,164,815.85","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515151","title":"Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515151","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515151?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071742,"startTime":"0","endTime":"0","summary":"Candel Therapeutics director Martine Zimmermann files initial beneficial ownership statementMartine Zimmermann filed an initial Form 3 as a director of Candel Therapeutics on Sept. 8, 2026.Disclaimer:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL259g1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666963515","title":"Candel Therapeutics Adds Independent Director to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2666963515","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666963515?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:48","pubTimestamp":1789044520,"startTime":"0","endTime":"0","summary":"Candel Therapeutics ( ($CADL) ) has shared an announcement. On September 6, 2026, Candel Therapeutics’ board expanded from ten to eleven members an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-adds-independent-director-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-adds-independent-director-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CADL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666593868","title":"Candel Therapeutics Appoints Martine Zimmermann, Pharmd, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666593868","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666593868?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:05","pubTimestamp":1789041900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA6TWHFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666381593","title":"Press Release: Candel Therapeutics Appoints Martine Zimmermann, PharmD, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666381593","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666381593?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:05","pubTimestamp":1789041900,"startTime":"0","endTime":"0","summary":"-- Regulatory and quality expertise strengthens Board as Candel advances","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4121","03160","IDNA","BK4555","BK4604","BK4539","DNA","TM","BK4099","BK4585","BK4109","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583005","title":"Candel Therapeutics Highlights Progress of Lead Oncology Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666583005?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:17","pubTimestamp":1788988674,"startTime":"0","endTime":"0","summary":"An announcement from Candel Therapeutics ( ($CADL) ) is now available. In September 2026, Candel Therapeutics detailed clinical progress and corpor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-highlights-progress-of-lead-oncology-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-highlights-progress-of-lead-oncology-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","DBB","CADL","LU2065732104.USD","BK4539","BK4139","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866214","title":"Candel Therapeutics Grants 31,400 Inducement Stock Options at $13.07 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866214?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:08","pubTimestamp":1788293334,"startTime":"0","endTime":"0","summary":"Candel Therapeutics grants 31,400 inducement stock options at $13.07 per shareCandel Therapeutics granted stock options for 31,400 shares to two new employees on Aug. 31, 2026.Exercise price set at US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLMczgd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4139","IE00BQXX3F31.USD","SG9999014039.USD","SG9999014021.USD","IE00BQXX3D17.EUR","CADL","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","BK4539","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4588","LU2210150020.SGD","IE00BQXX3C00.GBP","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BK4585","NDAQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886645","title":"Candel Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886645","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886645?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUABDGZLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664241869","title":"Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664241869","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664241869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immuno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354586/0/en/candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013716","title":"Candel Therapeutics CEO to Speak at Citi Biopharma Back to School Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013716","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:06","pubTimestamp":1787746009,"startTime":"0","endTime":"0","summary":"Candel Therapeutics CEO to speak at Citi Biopharma Back to School conference fireside chatCandel Therapeutics will join three New York investor conferences in September 2026, featuring analyst-led fir","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL83zf96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B64PRP62.GBP","LU0106831901.USD","LU1244550221.USD","SG9999014013.SGD","LU0098860793.USD","LU0320765646.SGD","BK4539","IE00BQXX3D17.EUR","LU0072461881.USD","IE00BN0W2T93.GBP","FTXO","NDAQ","BK4139","BK4534","LU2210149790.SGD","LU0130102774.USD","LU0203347892.USD","BK4504","LU1506573853.SGD","LU2125154935.USD","BK4207","BCDF","LU0162691827.USD","IE00B3QW5Z07.USD","LU0314104364.USD","LU0314106906.USD","LU0128525689.USD","IE00BN0W2W23.USD","SG9999014039.USD","CADL","LU2360032135.SGD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","TFNS","LU2417539215.USD","LU2210150020.SGD","IYF","LU0203345920.USD","IE00BN0W2V16.EUR","SG9999014021.USD","LU1668664300.SGD","LU1267930227.SGD","LU1144417596.USD","LU0052756011.USD","LU1201861249.SGD","LU0130517989.USD","LU0477156953.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874719","title":"Candel Therapeutics to Present at September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874719","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874719?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745900,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., Aug.  26, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351310/0/en/candel-therapeutics-to-present-at-september-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661459492","title":"Has Candel Therapeutics (CADL) Run Too Far Ahead On Widening Losses?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661459492","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661459492?lang=en_us&edition=fundamental","pubTime":"2026-08-24 02:21","pubTimestamp":1787509270,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) is back in focus after reporting second quarter 2026 results that showed a net loss of US$38.91 million. This compared with net income for the first half of 2025.\nSee our latest analysis for Candel Therapeutics.\nThe earnings release has come alongside strong momentum in Candel Therapeutics' stock, with a 1 month share price return of 37.34% and a year to date share price return of 141.36%. The 3 year total shareholder return is very large at around 9x, suggesting...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cadl/candel-therapeutics/news/has-candel-therapeutics-cadl-run-too-far-ahead-on-widening-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cadl/candel-therapeutics/news/has-candel-therapeutics-cadl-run-too-far-ahead-on-widening-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","BK4585","SPHQ","CADL","BK4588","BK4139","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473132","title":"Candel Therapeutics CTO Seshu Tyagarajan Sells 7,000 Shares for $84,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473132","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473132?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:31","pubTimestamp":1787171463,"startTime":"0","endTime":"0","summary":"Candel Therapeutics CTO Seshu Tyagarajan sells 7,000 shares for $84,000Candel Therapeutics CTO Seshu Tyagarajan sold 7,000 common shares on Aug. 17, 2026 at $12.Holdings fell to 76,865 shares followin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL7fp7Hy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Candel Therapeutics CTO Seshu Tyagarajan Sells 7,000 Shares for $84,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612540","title":"Candel Therapeutics is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612540","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612540?lang=en_us&edition=fundamental","pubTime":"2026-08-15 02:33","pubTimestamp":1786732380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CADL/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659214005","title":"Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659214005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659214005?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:10","pubTimestamp":1786720209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Candel Therapeutics (CADL), Acurx Pharmaceuticals (A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-candel-therapeutics-cadl-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-candel-therapeutics-cadl-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACXP","BK4539","CADL","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659214639","title":"BofA Adjusts Price Target on Candel Therapeutics to $12 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2659214639","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659214639?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:40","pubTimestamp":1786707609,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) has an average rating of buy and mean price target of $20.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.candeltx.com","stockEarnings":[{"period":"1week","weight":0.0157},{"period":"1month","weight":-0.1702},{"period":"3month","weight":0.1256},{"period":"6month","weight":1.2911},{"period":"1year","weight":1.0911},{"period":"ytd","weight":0.9504}],"compareEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":0.0069},{"period":"3month","weight":0.0581},{"period":"6month","weight":0.2165},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the?enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.056687},{"month":2,"riseRate":0.4,"avgChangeRate":0.052018},{"month":3,"riseRate":0.2,"avgChangeRate":-0.120448},{"month":4,"riseRate":0.4,"avgChangeRate":0.650234},{"month":5,"riseRate":1,"avgChangeRate":0.18781},{"month":6,"riseRate":0.2,"avgChangeRate":-0.088023},{"month":7,"riseRate":0.2,"avgChangeRate":0.003189},{"month":8,"riseRate":0.833333,"avgChangeRate":0.108437},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.040349},{"month":10,"riseRate":0.4,"avgChangeRate":-0.110246},{"month":11,"riseRate":0,"avgChangeRate":-0.079739},{"month":12,"riseRate":0.8,"avgChangeRate":0.288433}],"exchange":"NASDAQ","name":"Candel Therapeutics, Inc.","nameEN":"Candel Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Candel Therapeutics, Inc.(CADL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Candel Therapeutics, Inc.,CADL,Candel Therapeutics, Inc.股票,Candel Therapeutics, Inc.股票老虎,Candel Therapeutics, Inc.股票老虎国际,Candel Therapeutics, Inc.行情,Candel Therapeutics, Inc.股票行情,Candel Therapeutics, Inc.股价,Candel Therapeutics, Inc.股市,Candel Therapeutics, Inc.股票价格,Candel Therapeutics, Inc.股票交易,Candel Therapeutics, Inc.股票购买,Candel Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Candel Therapeutics, Inc.(CADL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}